ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naive patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC)

被引：0

作者：

Smith, M. R. ^{[1
]}

Parker, C. C. ^{[2
]}

Saad, F. ^{[3
]}

Miller, K. ^{[4
]}

Tombal, B. ^{[5
]}

Ng, Q. S. ^{[6
]}

Boegemann, M. ^{[7
]}

Matveev, V. ^{[8
]}

Piulats, J. M. ^{[9
]}

Zucca, L. E. ^{[10
]}

Heidenreich, A. ^{[11
]}

Kakehi, Y. ^{[12
]}

Zhang, A. ^{[13
]}

Krissel, H. ^{[14
]}

Shen, J. ^{[15
]}

Wagner, V. ^{[16
]}

Higano, C. ^{[17
,18
]}

机构：

[1] Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USA

[2] Royal Marsden NHS Fdn Trust, Dept Urol, Inst Canc Res, Sutton, Surrey, England

[3] Univ Montreal Hosp Ctr, Dept Urol, Montreal, PQ, Canada

[4] Charite, Dept Med Oncol, Berlin, Germany

[5] Clin Univ St Luc, Dept Urol, Brussels, Belgium

[6] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore

[7] Univ Munster, Med Ctr, Dept Clin Oncol Urol, Munster, Germany

[8] NN Blokhin Canc Res Ctr, Dept Urol, Moscow, Russia

[9] Catalan Canc Inst, Dept Med Oncol, Barcelona, Spain

[10] Barretos Canc Hosp, Dept Med Oncol, Barretos, Brazil

[11] Univ Hosp Cologne, Dept Urol, Cologne, Germany

[12] Kagawa Univ, Dept Urol, Takamatsu, Kagawa, Japan

[13] Bayer HealthCare Pharmaceut, Oncol, Whippany, NJ USA

[14] Bayer AG, Oncol, Berlin, Germany

[15] Bayer HealthCare Pharmaceut, Clin Stat, Whippany, NJ USA

[16] Bayer Consumer Care AG, Oncol, Basel, Switzerland

[17] Univ Washington, Dept Med Oncol, Seattle, WA 98195 USA

[18] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA30

引用

页数：1